BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Image Results

Loading...
Loading...

ELAPRASE Pages on BioPortfolio:

Biotechnology News ELAPRASE Search
Biotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directory.
http://www.bioportfolio.co.uk/ELAPRASE-news.htm...

BioPortfolio - Elaprase
Elaprase - BioPortfolio - Indepth. ... recently searched for, or most viewed. Search for Elaprase across BioPortfolio, or for Elaprase Research Reports ...
http://www.bioportfolio.com/indepth/Elaprase.html...

BioPortfolio's Approved Drugs News by Tradename - E
ELAPRASE · ELASE-CHLOROMYCETIN ...
http://www.bioportfolio.co.uk/approved_drugs/approved_drug_n...

BioPortfolio - Mucopolysaccharidosis Ii - InDepth
Japan Elaprase((R)) Treatment (JET) study: Idursulfase enzyme replacement therapy in ... Home treatment with Elaprase and Naglazyme is safe in patients
with ...
http://www.bioportfolio.com/indepth/Mucopolysaccharidosis_Ii...

BioPortfolio.com - BioWeb MORPHINE MORPHINE SULFATE Search
5 Feb 2008 ... Currently, we have in-licensed the rights to sell eleven drugs, Amphocil from Three Rivers Pharmaceuticals, Elaprase and Replagal from Shire ...
http://www.bioportfolio.co.uk/MORPHINE+MORPHINE+SULFATE-biow...

BioPortfolio - N-Acetylgalactosamine-4-Sulfatase - InDepth
Home treatment with Elaprase and Naglazyme is safe in patients with mucopolysaccharidoses types II · and VI, respectively. Enzyme replacement
therapy for ...
http://www.bioportfolio.com/indepth/N-Acetylgalactosamine-4-...

BioPortfolio Limited Shire plc: PharmaVitae Profile
Elaprase 125. Overview 125. Sales forecast 126. Replagal 128. Overview 128. Sales forecast 129 ... Table 44: Elaprase: sales forecast ($m), 2007-13 126 ...
http://www.bioportfolio.com/cgi-bin/acatalog/2063.html...

BioPortfolio - Mucopolysaccharidosis Vi - InDepth
Home treatment with Elaprase and Naglazyme is safe in patients with mucopolysaccharidoses types II. 1/4. Page 2. and VI, respectively. ...
http://www.bioportfolio.com/indepth/Mucopolysaccharidosis_Vi...

BioPortfolio - Mucopolysaccharidosis - InDepth
Oct;155(4 Suppl):S32-46. (DOI Direct Link). • Japan Elaprase((R)) Treatment (JET ) study: Idursulfase enzyme replacement therapy in adult patients ...
http://www.bioportfolio.com/indepth/Mucopolysaccharidosis.pd...

BioPortfolio News: - Shire Continues to Deliver Excellent...
Expressed on a CER basis, sales increased by 20% (ELAPRASE is primarily sold in US dollars and Euros). The sales growth was driven by increased volumes ...
http://www.bioportfolio.com/news/Shire-Continues-to-Deliver-...

Results from other life science and pharmaceutical sites:

Shire plc Annual Review 2008 - ELAPRASE
ELAPRASE is the first and only enzyme replacement therapy for Hunter syndrome-a rare, progressive and life-threatening condition that primarily affects boys ...
http://www.shire.com/shire/financialReports/ar2008/content/p...

International Approvals: Nexavar, Elaprase, Aranesp
5 Nov 2007 ... Europe has approved a new indication for sorafenib tosylate tablets (Nexavar) and an expanded indication for darbepoetin alfa (Aranesp); ...
http://www.medscape.com/viewarticle/565318...

Home treatment with Elaprase and Naglazyme is safe in patients ...
In this report we demonstrate the safety of home treatment with Elaprase for mucopolysaccharidosis type II (17 patients) and Naglazyme for ...
http://www.ncbi.nlm.nih.gov/pubmed/18923918...

International Approvals: Tysabri, Elaprase, Invega
9 Jul 2007 ... The United Kingdom has approved natalizumab intravenous infusion (Tysabri), Health Canada has approved idursulfase intravenous infusion ...
http://www.medscape.com/viewarticle/559429...

Japan Elaprase((R)) Treatment (JET) study: Idursulfase enzyme ...
Japan Elaprase((R)) Treatment (JET) study: Idursulfase enzyme replacement therapy in adult patients with attenuated Hunter syndrome (Mucopolysaccharidosis
...
http://www.ncbi.nlm.nih.gov/pubmed/19773189...

International Approvals: Mirena, Champix, Elaprase
2 Feb 2007 ... Japan has approved a long-acting intrauterine contraceptive system (Mirena), Canada has approved varenicline tartrate tablets (Champix), ...
http://www.medscape.com/viewarticle/551678...

Shire Pharmaceuticals Announces Approval of ELAPRASE(R ...
27 May 2008 ... Shire Pharmaceuticals (SHPGY) Announces Approval of ELAPRASE(R) (idursulfase) in Brazil First and Only Treatment for Hunter Syndrome Now ...
http://www.biospace.com/news_story.aspx?NewsEntityId=97814...

International Approvals: Prexige, Elaprase, Micera
13 Aug 2007 ... Canada has approved an expanded indication for lumiracoxib tablets (Prexige) and idursulfase 2-mg/mL solution (Elaprase); ...
http://www.medscape.com/viewarticle/561315...

Shire Pharmaceuticals Group plc's ELAPRASE(TM) (Idursulfase ...
ELAPRASE is the first and only treatment approved for people suffering from Hunter syndrome. The product, which is given as weekly infusions, replaces the
...
http://www.biospace.com/news_story.aspx?NewsEntityId=25128...

DailyMed: About DailyMed
Each vial of ELAPRASE contains a 2.0 mg/mL solution of idursulfase protein (6.0 mg) .... ELAPRASE is a formulation of idursulfase, a purified form of human ...
http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=11721...

Google Custom Search

Search
  


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.